Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

24.26 -1.54 (-5.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
STAAR Surgical Revises Strategy Amid Slow U.S. Adoption, Analyst Adjusts Rating to Market Perform
William Blair downgraded Staar Surgical Co (NASDAQ: STAA) from Outperform to Market Perform, noting a lack 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
 
Via Benzinga
What 4 Analyst Ratings Have To Say About Staar Surgical
 
Via Benzinga
2 Stocks With Unstoppable Growth Potential for the Next Decade
There isn't much holding either of these companies back from expanding more. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Analyst Ratings for Staar Surgical
 
Via Benzinga
Recap: Staar Surgical Q1 Earnings
 
Via Benzinga
The Latest Analyst Ratings for Staar Surgical
 
Via Benzinga
Expert Ratings for Staar Surgical
 
Via Benzinga
EVO ICL Sponsors Jonas Brothers’ The Tour
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports First Quarter 2023 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report First Quarter Results on May 3, 2023
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
From STAAR Surgical Company
Via Business Wire
Staar Surgical Earnings Preview
 
Via Benzinga
Analyst Expectations for Staar Surgical's Future
 
Via Benzinga
Stephens & Co. Maintains Overweight Rating for Staar Surgical: Here's What You Need To Know
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results
From STAAR Surgical Company
Via Business Wire
7 Analysts Have This to Say About Staar Surgical
 
Via Benzinga
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023
From STAAR Surgical Company
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
 
Via Benzinga
Analyst Reiterates This Ophthalmology Device Stock On Steep But Attractive Risk/Reward
Needham analyst expects the U.S. ICL market of more than $2.4 billion, despite some investors considering the market to be niche, with STAAR Surgical Company (NASDAQ: STAA) becoming a major player in... 
Via Benzinga
Neogen Stock Earns Relative Strength Rating Upgrade
Neogen stock got a positive adjustment to its Relative Strength (RS) Rating, rising to 79 on Thursday from 66 a day earlier. 
Via Investor's Business Daily
Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
From STAAR Surgical Company
Via Business Wire
Why Shares of STAAR Surgical Jumped 23.7% This Week
The new CEO made a major purchase of the company's stock on Monday. 
Via The Motley Fool
Goldman Sachs To $492? Here Are 10 Other Price Target Changes For Wednesday
 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO
From STAAR Surgical Company
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.